Vaccines still in Emergency Use Authorization phase, not yet FDA approved
+ CNBC: Scientists blast U.S. push for Covid vaccine booster shots as premature, say data isn’t compelling
+ The Washington Post: Biden team tries to get ahead of the virus — and maybe the science — with decision on booster shots
+ Seeking Alpha: CDC postpones COVID-19 booster shot review amid debate over third dose
+ Bloomberg: Booster Review Delayed by CDC as Debate Swirls Over 3rd Shot
+ Reuters: U.S. reviewing if Moderna shot tied to higher heart inflammation risk – Washington Post
+ Seeking Alpha: Moderna COVID-19 vaccine being probed in U.S. for higher-than-expected risk of side effect
+ Seeking Alpha: Moderna, BioNTech in selloff despite interest in COVID-19 booster shots
+ The Washington Post: U.S. review of possible link between Moderna vaccine and uncommon side effect delays adolescent approval
Post a comment
One comment
Thank you Steve for this timely information. So much is not widly shared with (or purposly kept from) the public about these jabs, the health risks and potential harm they can do to the human body. Keep up the great work my good friend. Much Love.
By submitting a comment you grant Yelm Community Blog a perpetual license to reproduce your words and name/web site in attribution. Inappropriate and irrelevant comments will be removed at an admin’s discretion. Your email is used for verification purposes only, it will never be shared.